Dianthus Therapeutics (DNTH) earnings

Earnings (net income) · fiscal 2025
-$162.34M

Dianthus Therapeutics (DNTH) reported net income of -$162.34M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$84.97M. Figures as of 18 Nov 2026, 00:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$162.34M
Highest on record
-$9.43Mfiscal 2016
Lowest on record
-$162.34Mfiscal 2025
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Dianthus Therapeutics earnings, in more detail

Across the 10 fiscal years on record (2016–2025), the highest was -$9.43M in fiscal 2016 and the lowest -$162.34M in fiscal 2025.

History · 10 fiscal years

Earnings (net income) by fiscal year

Dianthus Therapeutics earnings, year by year

Dianthus Therapeutics (DNTH) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$162.34M—
2024-$84.97M—
2023-$43.56M—
2022-$28.48M—
2021-$71.14M—
2020-$74.94M—
2019-$76.77M—
2018-$57.52M—
2017-$35.49M—
2016-$9.43M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Dianthus Therapeutics and comparable companies
CompanyEarnings (net income)Fiscal year
LivaNova LIVN-$242.47M2025
Ionis Pharmaceuticals IONS-$381.39M2025
Dianthus Therapeutics DNTH-$162.34M2025
MiniMed Group MMED-$333.00M2026
Adaptive Biotechnologies ADPT-$59.50M2025
Heartflow HTFL-$116.79M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DNTH

Dianthus Therapeutics, figure by figure

Dianthus Therapeutics (DNTH) overview: price, valuation and scorecardAll health care companies by market value

Dianthus Therapeutics earnings: questions and answers

What is Dianthus Therapeutics's net income?

Dianthus Therapeutics (DNTH) reported net income of -$162.34M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$84.97M.

What are the highest and lowest net income figures on record for Dianthus Therapeutics?

Across the 10 fiscal years on record (2016–2025), the highest was -$9.43M in fiscal 2016 and the lowest -$162.34M in fiscal 2025.

How is Dianthus Therapeutics's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Dianthus Therapeutics (DNTH) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/DNTH/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.